FI932959A - KINOXALIN DERIVATIVES, DERAS FRAMSTAELLNING OCH ANVAENDNING I LAEKEMEDEL - Google Patents

KINOXALIN DERIVATIVES, DERAS FRAMSTAELLNING OCH ANVAENDNING I LAEKEMEDEL Download PDF

Info

Publication number
FI932959A
FI932959A FI932959A FI932959A FI932959A FI 932959 A FI932959 A FI 932959A FI 932959 A FI932959 A FI 932959A FI 932959 A FI932959 A FI 932959A FI 932959 A FI932959 A FI 932959A
Authority
FI
Finland
Prior art keywords
laekemedel
deras framstaellning
framstaellning och
och anvaendning
kinoxalin
Prior art date
Application number
FI932959A
Other languages
Finnish (fi)
Other versions
FI932959A0 (en
Inventor
Andreas Huth
Ralph Schmiechen
Ilse Beetz
Ingrid Schumann
Lechoslaw Turski
Peter Andreas Loeschmann
David Norman Stephens
Dieter Seidelmann
Martin Krueger
Dieter Rahtz
Peter Hoelscher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4135871A external-priority patent/DE4135871A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI932959A publication Critical patent/FI932959A/en
Publication of FI932959A0 publication Critical patent/FI932959A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI932959A 1991-10-26 1993-06-24 Quinoxaline is derivatized, derivatized and used in laekemedel FI932959A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4135871A DE4135871A1 (en) 1991-10-26 1991-10-26 New quinoxaline derivs.
DE4224200 1992-07-17
PCT/DE1992/000895 WO1993008173A1 (en) 1991-10-26 1992-10-25 Quinoxaline derivates with affinity for quisqualate-receptors

Publications (2)

Publication Number Publication Date
FI932959A true FI932959A (en) 1993-06-24
FI932959A0 FI932959A0 (en) 1993-06-24

Family

ID=25908683

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932959A FI932959A0 (en) 1991-10-26 1993-06-24 Quinoxaline is derivatized, derivatized and used in laekemedel

Country Status (17)

Country Link
EP (1) EP0565683A1 (en)
JP (1) JP3258008B2 (en)
KR (1) KR100262371B1 (en)
CN (1) CN1038840C (en)
AU (1) AU664212B2 (en)
CA (1) CA2099270A1 (en)
CZ (1) CZ286351B6 (en)
FI (1) FI932959A0 (en)
HU (1) HUT64756A (en)
IL (1) IL103538A (en)
NO (1) NO304693B1 (en)
NZ (1) NZ244896A (en)
PL (1) PL171125B1 (en)
PT (1) PT101004B (en)
RU (1) RU2117663C1 (en)
SK (1) SK281518B6 (en)
WO (1) WO1993008173A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162491D0 (en) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocyclic compounds, their preparation and pharmaceutical preparations containing the compounds
EP0647137B1 (en) * 1992-06-22 2008-08-13 The Regents Of The University Of California Glycine receptor antagonists and the use thereof
DE4314592A1 (en) * 1993-04-28 1994-11-03 Schering Ag Benzo (f) quinoxalinedione derivatives, their production and use in medicinal products
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4428152A1 (en) * 1994-06-22 1996-01-04 Basf Ag New amido-quinoxalinediones, their production and use
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
HU223945B1 (en) * 1994-09-27 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. 1,2,3,4-tetrahydroquinoxalindione derivatives and pharmaceutical compositions containing them
DE4439493A1 (en) * 1994-10-25 1996-05-02 Schering Ag New quinoxalinedione derivatives, their production and use in pharmaceuticals
DE4439492A1 (en) * 1994-10-25 1996-05-02 Schering Ag New quinoxalinedione derivatives, their production and use in pharmaceuticals
US6110911A (en) * 1995-06-07 2000-08-29 Warner-Lambert Company Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE19521058A1 (en) * 1995-06-09 1996-12-12 Basf Ag Process for the preparation of aromatic-containing polyether polyols
DE19545251A1 (en) * 1995-11-24 1997-05-28 Schering Ag New quinoxalinedione derivatives, their production and use in pharmaceuticals
TW448171B (en) * 1996-06-06 2001-08-01 Yamanouchi Pharma Co Ltd Imidazole-substituted quinoxalinedione derivatives
DE19624808A1 (en) 1996-06-21 1998-01-02 Basf Ag Pyrrolylquinoxalinediones, their preparation and use
DE19728326A1 (en) * 1997-06-27 1999-01-07 Schering Ag New quinoxalinedione derivatives, their production and use in pharmaceuticals
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
FR2769309B1 (en) 1997-10-08 2001-06-15 Oreal KERATINIC FIBER OXIDATION DYE COMPOSITION COMPRISING AN AMINO ACID DERIVATIVE AS AN OXIDATION BASE AND NOVEL AMINO ACID DERIVATIVES
GB0311406D0 (en) * 2003-05-17 2003-06-25 Queen Mary & Westfield College Substituted phosphonate fluorescent sensors,and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0118982A1 (en) * 1983-02-01 1984-09-19 Sumitomo Chemical Company, Limited Organic phosphorous quinoxalinone and their production and use
NO179551C (en) * 1987-11-10 1996-10-30 Novo Nordisk As Analogous Process for Preparing Therapeutically Effective Quinoxaline Compounds
DK69790D0 (en) * 1990-03-16 1990-03-16 Novo Nordisk As HETEROCYCLIC COMPOUNDS, THEIR PREPARATION OF USE

Also Published As

Publication number Publication date
PT101004A (en) 1994-01-31
AU2889492A (en) 1993-05-21
NO932344L (en) 1993-06-25
PT101004B (en) 1999-10-29
SK281518B6 (en) 2001-04-09
PL299929A1 (en) 1994-04-05
CN1072929A (en) 1993-06-09
IL103538A (en) 2001-07-24
HUT64756A (en) 1994-02-28
IL103538A0 (en) 1993-03-15
JP3258008B2 (en) 2002-02-18
JPH06503583A (en) 1994-04-21
CN1038840C (en) 1998-06-24
WO1993008173A1 (en) 1993-04-29
NZ244896A (en) 1995-07-26
CZ138793A3 (en) 1994-01-19
EP0565683A1 (en) 1993-10-20
KR930703271A (en) 1993-11-29
NO304693B1 (en) 1999-02-01
SK72793A3 (en) 1993-10-06
PL171125B1 (en) 1997-03-28
NO932344D0 (en) 1993-06-25
CZ286351B6 (en) 2000-03-15
RU2117663C1 (en) 1998-08-20
FI932959A0 (en) 1993-06-24
KR100262371B1 (en) 2000-08-01
AU664212B2 (en) 1995-11-09
CA2099270A1 (en) 1993-04-27
HU9301877D0 (en) 1993-09-28

Similar Documents

Publication Publication Date Title
MX9205145A (en) NEW DERIVATIVES HETEROCICLICOS.
NL300250I1 (en) Chinuclidine derivatives.
NO922182D0 (en) CRYSTALLINIC OXATATOLAN DERIVATIVES
FI921943A (en) POROEST BIKAKSMATERIAL, FOERFARANDE FOER FRAMSTAELLNING AV DET OCH ANVAENDNING AV DET
FI923947A (en) FOERFARANDE FOER PULSBREDDSMODULATION FOER OEKAD LINEARITET, MINSKAD KOMMUTATIONSFOERLUST OCH OEKAD UTSPAENNING I EN VAEXELRIKTARE / OMRIKTARE
FI932959A (en) KINOXALIN DERIVATIVES, DERAS FRAMSTAELLNING OCH ANVAENDNING I LAEKEMEDEL
DE69110254T2 (en) Hydroxyquinolone derivatives.
FI925763A (en) FUNGICIDA 2-IMIDAZOLIN-5-ON-OCH 2-IMIDAZOLINE-5-THION DERIVATIVES
FI922721A (en) AMMUNITIONSKONPONENT MED LAOG SKADEEGENSKAPER, MED EN TVAOKOMPONENTIG EXPLOSIONSLADDNING OCH FOERFARANDE FOER UPPNAOENDE AV EN FRAGMENTATIONSEFFEKT
TR26336A (en) SUBSTITUTED PIRAZOLINE DERIVATIVES
FI891122A0 (en) N-CYCLOPROPYLANILINER OCH DERAS ANVAENDNING I FOERFARANDET FOER FRAMSTAELLNING AV 1-CYKLOPROPYLKINOLONKARBOXYLSYROR OCH DERAS DERIVAT.
FI922390A (en) INITIATORSUSPENSIONER, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI922491A (en) FOERBAETTRAD, FOSFAT OCH ENZYMER INNEHAOLLANDE, PULVERFORMIG DISKMEDELSKOMPOSITION FOER AUTOMATISKA DISKMASKINER
FI922979A (en) 2-PIPERIDIN-1-YL) ETHANOL DERIVATIVES, DERAS FRAMSTAELLNING OCH TERAPEUTISKA ANVAENDNING
FI922377A (en) GLASBLANDNING, DAERAV FRAMSTAELLDA GLASFIBRER OCH DERAS FRAMSTAELLNINGSFOERFARANDE
FI922492A (en) FOSFAT OCH ENZYMER INNEHAOLLANDE, PULVERFORMIG DISKMEDELSKOMPOSITION FOER AUTOMATISKA DISKMASKINER
FI925469A (en) Thiazolylsubstituted quinollymethoxyphenylate derivatives
FI922389A0 (en) ANORDINATION FOR FRAMSTAELLNING AV EN PRESSMANTEL AVSEDD FOER BRUK I PAPPERSINDUSTRIN OCH PRESSMANTEL FRAMSTAELLD DAERMED.
FI922876A (en) HETEROCYCLISKA FOERENINGAR MED RENINHAEMMANDE EGENSKAPER, FOERFARANDE FOERFRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA
DE59106761D1 (en) N-acylpyrrolidine derivatives.
FI925974A (en) HUMANT ROTAVIRUS-HCR3, NYORGANISERADE STAMMAR AV DETTA OCH VACCINKOMPOSITIONER INNEHAOLLANDE DESSA
FI922980A (en) 2-PIPERIDINYLPYRIMIDINE-4-CARBOXAM DERIVATIVES, FRAMSTAELLNING AV DESSA OCHTERAPEUTISK ANVAENDNING AV DESSA
FI925639A (en) ISOXAZOLYLIMIDAZOLDERIVAT, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING I LAEKEMEDEL
FI923998A (en) DERIVATIVES AVERAGE BFGF, DERAS ANALOGER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
KR930702353A (en) 2-carbapenem derivatives